Go Pro

Shattuck Labs (STTK) 10K Form and Latest SEC Filings 2026

Shattuck Labs logo
$6.43 -0.21 (-3.16%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$6.42 0.00 (-0.08%)
As of 06:35 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Shattuck Labs SEC Filings & Recent Activity

Shattuck Labs (NASDAQ:STTK) has submitted 307+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Shattuck Labs's financial statements. The most recent filing was a Form 4 submitted on July 7, 2026.

Form 4
Shattuck Labs, Inc. Reports Ownership Change on Jul. 7, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Shattuck Labs Files Current Report on Jun. 11, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Shattuck Labs Files Quarterly Report on May. 7, 2026

The 10-Q contains Shattuck Labs's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Shattuck Labs SEC Filing History

Browse Shattuck Labs' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
07/07/2026 6:00 PM
Shattuck Labs (1680367) Issuer
Shukla Abhinav A. (1923377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2026 7:15 PM
Pandite Arundathy N. (1827232) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2026 7:17 PM
Shattuck Labs (1680367) Issuer
Shukla Abhinav A. (1923377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 3:19 PM
Shattuck Labs (1680367) Subject
Shukla Abhinav A. (1923377) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2026 3:10 PM
Shattuck Labs (1680367) Subject
Shukla Abhinav A. (1923377) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/15/2026 5:10 PM
ORBIMED ADVISORS LLC (1055951) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13D/A
06/15/2026 5:12 PM
ORBIMED ADVISORS LLC (1055951) Reporting
OrbiMed Capital GP IX LLC (1920574) Reporting
OrbiMed Genesis GP LLC (1808744) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2026 5:13 PM
Ashiya Mona (1794070) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2026 8:00 PM
Redmile Group, LLC (1425738) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13D/A
06/11/2026 4:00 PM
Shattuck Labs (1680367) Issuer
SIEGALL CLAY B (1167496) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2026 7:25 AM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2026 5:01 AM
Shattuck Labs (1680367) Filer
Form 424B5
06/09/2026 7:56 PM
Ashiya Mona (1794070) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2026 7:58 PM
ORBIMED ADVISORS LLC (1055951) Reporting
OrbiMed Capital GP IX LLC (1920574) Reporting
OrbiMed Genesis GP LLC (1808744) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2026 4:15 PM
Shattuck Labs (1680367) Filer
Form 424B5
06/09/2026 3:28 PM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2026 7:00 PM
Boudreau Helen M (1661481) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2026 7:00 PM
Shattuck Labs (1680367) Issuer
SIEGALL CLAY B (1167496) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2026 7:00 PM
Ashiya Mona (1794070) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2026 7:00 PM
Gibson Neil W (1555918) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2026 7:00 PM
Golumbeski George (1586660) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2026 7:00 PM
Baker Daniel G. (2046802) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2026 4:00 PM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2026 5:05 AM
Shattuck Labs (1680367) Issuer
SIEGALL CLAY B (1167496) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2026 4:01 PM
Shattuck Labs (1680367) Issuer
Shukla Abhinav A. (1923377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 6:46 AM
Shattuck Labs (1680367) Issuer
Stout Stephen (1970664) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 9:06 AM
Shattuck Labs (1680367) Subject
Form SCHEDULE 13G/A
05/14/2026 7:10 PM
Neill Andrew R (1827204) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2026 7:00 PM
Pandite Arundathy N. (1827232) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2026 7:05 PM
Shattuck Labs (1680367) Issuer
Shukla Abhinav A. (1923377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2026 5:05 AM
Schreiber Taylor (1601942) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2026 4:36 PM
Shattuck Labs (1680367) Issuer
Stout Stephen (1970664) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2026 3:33 PM
Pandite Arundathy N. (1827232) Reporting
Shattuck Labs (1680367) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/12/2026 3:17 PM
Shattuck Labs (1680367) Subject
Shukla Abhinav A. (1923377) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2026 5:54 AM
Shattuck Labs (1680367) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2026 5:34 AM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2026 5:40 AM
Shattuck Labs (1680367) Filer
Form ARS
04/08/2026 5:30 AM
Shattuck Labs (1680367) Filer
Form DEF 14A
04/08/2026 5:35 AM
Shattuck Labs (1680367) Filer
Form DEFA14A
03/05/2026 5:28 AM
Shattuck Labs (1680367) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2026 5:23 AM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump's New Dollar (Ad)

Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel

Watch the free briefing and see the three steps to prepare today
02/06/2026 9:08 AM
Shattuck Labs (1680367) Subject
T. Rowe Price Investment Management, Inc. (1897612) Filed by
Form SCHEDULE 13G
01/27/2026 3:14 PM
Pandite Arundathy N. (1827232) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2026 4:19 PM
Shattuck Labs (1680367) Filer
Form 424B5
01/22/2026 4:22 PM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2026 11:15 PM
Shattuck Labs (1680367) Filer
Form EFFECT
01/13/2026 3:50 PM
DeYoung Casi (1652066) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:55 PM
Shattuck Labs (1680367) Issuer
Stout Stephen (1970664) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:40 PM
Schreiber Taylor (1601942) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:42 PM
Neill Andrew R (1827204) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:45 PM
Pandite Arundathy N. (1827232) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:48 PM
Shattuck Labs (1680367) Issuer
Shukla Abhinav A. (1923377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2026 3:16 PM
Shattuck Labs (1680367) Filer
Form S-3
Registration statement under Securities Act of 1933  
11/13/2025 6:38 PM
Prosight Management, LP (1617201) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13G/A
11/06/2025 4:15 PM
Shattuck Labs (1680367) Filer
Form 8-K/A
11/06/2025 3:32 PM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2025 3:34 PM
Shattuck Labs (1680367) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/28/2025 11:15 PM
Shattuck Labs (1680367) Filer
Form EFFECT
09/02/2025 8:52 PM
ORBIMED ADVISORS LLC (1055951) Reporting
OrbiMed Capital GP IX LLC (1920574) Reporting
OrbiMed Genesis GP LLC (1808744) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 8:53 PM
ORBIMED ADVISORS LLC (1055951) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13D
09/02/2025 8:48 PM
ORBIMED ADVISORS LLC (1055951) Reporting
OrbiMed Capital GP IX LLC (1920574) Reporting
OrbiMed Genesis GP LLC (1808744) Reporting
Shattuck Labs (1680367) Issuer
Form 3
Initial statement of beneficial ownership of securities  
09/02/2025 8:50 PM
Ashiya Mona (1794070) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 5:35 AM
Baker Daniel G. (2046802) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 5:35 AM
Ashiya Mona (1794070) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2025 5:30 AM
Ashiya Mona (1794070) Reporting
Shattuck Labs (1680367) Issuer
Form 3
Initial statement of beneficial ownership of securities  
09/02/2025 5:30 AM
Baker Daniel G. (2046802) Reporting
Shattuck Labs (1680367) Issuer
Form 3
Initial statement of beneficial ownership of securities  
08/27/2025 5:30 AM
Schreiber Taylor (1601942) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2025 5:30 AM
Shattuck Labs (1680367) Issuer
Shukla Abhinav A. (1923377) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2025 5:30 AM
Shattuck Labs (1680367) Issuer
SIEGALL CLAY B (1167496) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2025 5:30 AM
Neill Andrew R (1827204) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2025 5:30 AM
Shattuck Labs (1680367) Issuer
Stout Stephen (1970664) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2025 4:00 PM
Green Jeremy (1650527) Reporting
Redmile Group, LLC (1425738) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2025 4:01 PM
Redmile Group, LLC (1425738) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13D/A
08/26/2025 5:35 AM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2025 5:40 AM
Shattuck Labs (1680367) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2025 5:37 AM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2025 8:00 PM
Redmile Group, LLC (1425738) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13D/A
08/05/2025 5:40 AM
Shattuck Labs (1680367) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2025 8:00 PM
Green Jeremy (1650527) Reporting
Redmile Group, LLC (1425738) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 8:01 PM
Lee Michael Stewart (1748010) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 6:02 PM
BlackRock, Inc. (2012383) Filed by
Shattuck Labs (1680367) Subject
Form SCHEDULE 13G/A
07/16/2025 3:21 PM
Golumbeski George (1586660) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 3:25 PM
Sasser Amy Kate (2013454) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 3:28 PM
Shattuck Labs (1680367) Issuer
SIEGALL CLAY B (1167496) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 3:09 PM
Brous Tyler (1827387) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 3:13 PM
Brownstein Carrie (1894232) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025 3:17 PM
Gibson Neil W (1555918) Reporting
Shattuck Labs (1680367) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Shattuck Labs SEC Filings - Frequently Asked Questions

Shattuck Labs (STTK) has submitted 307+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Shattuck Labs's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Shattuck Labs's financial statements page.

The most recent filing was a Form 4 submitted on July 7, 2026. This was an insider ownership change filed by 4 - Shattuck Labs, Inc. (0001680367) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:STTK) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners